O'Keefe, Stephen J D <br/><br/>
Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.  [electronic resource] 

 -  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association  Jul 2013 
 - 815-23.e1-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1542-7714 
<br/><br/><label>Standard No.: </label>10.1016/j.cgh.2012.12.029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Double-Blind Method<br/>Female<br/>Gastrointestinal Agents--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Parenteral Nutrition<br/>Peptides--adverse effects<br/>Short Bowel Syndrome--drug therapy<br/>Treatment Outcome<br/>Young Adult